Sign up to see all 5.
Sign up to see all 5.
A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
VC
Vivo Capital, LLC
|
3.2M | 6.84% | Unchanged | Q1 '26 | 1.4% | |
|
Shares held by quarter
Peak holding3.2M (Q1'26)
Change over 8 quarters+3.2M
Share of the company6.840%
|
||||||
|
CC
Commodore Capital LP
|
2.9M | 6.36% | +600.0K (+25.7%) | Q1 '26 | 0.9% | |
|
Shares held by quarter
Peak holding2.9M (Q2'26)
Change over 8 quarters+2.9M
Share of the company6.360%
|
||||||
28 more super investors behind a free account
See every manager holding AN2 Therapeutics, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$4.13M | 853.0K | 1.85% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$2.92M | 603.1K | 1.31% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding AN2 Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
AK
Aziz Kabeer
Insider
|
7.5M | 16.17% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company16.170%
|
||||||
|
LB
Leonard Braden Michael
Insider
|
3.2M | 6.98% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company6.980%
|
||||||
13 more holders behind a free account
See every insider and 5%+ holder of AN2 Therapeutics, Inc..
Sign up freeLoading...